Jun 14, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif. and SEOUL, South Korea, June 14, 2017 -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology...
FRONTEO Announces Notice Concerning FRONTEO’s Grant of Stock Options (Subscription Rights to Shares)
Jun 14, 2017 12:01 pm UTC| Business
TOKYO, June 14, 2017 -- FRONTEO, Inc. (the “Company”) today announced as follows that its Board of Directors held on June 14, 2017 resolved to propose “Issuance of Subscription Rights to Shares as Stock Options” for...
VBL Therapeutics to Present at Upcoming June Conferences
Jun 14, 2017 12:01 pm UTC| Business
TEL AVIV, Israel, June 14, 2017 -- VBL Therapeutics (Nasdaq:VBLT) today announced Prof. Dror Harats, CEO, will provide a corporate overview at the 2017 BIO International Convention in San Diego and participate in a...
Celsion Corporation Regains Compliance with NASDAQ Listing Requirements
Jun 14, 2017 12:01 pm UTC| Business
LAWRENCEVILLE, N.J., June 14, 2017 -- Celsion Corporation (NASDAQ:CLSN), an oncology drug development company, today announced that it received notice from The NASDAQ Stock Market LLC (NASDAQ) on June 13, 2017...
Jun 14, 2017 12:01 pm UTC| Business
The positive Phase III top-line results indicate that the study successfully met its primary endpoint and BEKINDA® 24 mg was shown to be effective, safe and well tolerated in patients with acute gastroenteritis and...
Motorcar Parts of America Reports Record Fiscal 2017 Fourth Quarter and Year-End Results
Jun 14, 2017 12:01 pm UTC| Business
LOS ANGELES, June 14, 2017 -- Motorcar Parts of America, Inc. (Nasdaq:MPAA) today reported record sales for its fiscal 2017 fourth quarter and year ended March 31, 2017 on a reported and adjusted basis. Net sales for...
AIT Therapeutics Announces Appointment of Steve Lisi as Chief Executive Officer
Jun 14, 2017 12:00 pm UTC| Business
REHOVOT, Israel and NEW YORK, June 14, 2017 -- AIT Therapeutics Inc. (OTC:AITB), a clinical stage anti-microbial therapeutic company treating respiratory diseases with nitric oxide (NO), today announced the appointment...